Travis Criteria for Severe Ulcerative Colitis
Predicts response to IV corticosteroids in acute severe ulcerative colitis (ASUC). The Oxford criteria identify patients who may need ciclosporin or urgent colectomy by day 3.
Score interpretation
Neither more than 8 stools, nor 3–8 stools with CRP > 45 mg/L, on day 3 of IV corticosteroids.
→ Continue IV corticosteroids with daily review; a poor response on later days still needs rescue therapy or surgical review.
More than 8 stools, or 3–8 stools with CRP > 45 mg/L, on day 3: 85% needed colectomy in Travis 1996.
→ Urgent gastroenterology and colorectal surgical review; rescue therapy (ciclosporin or infliximab) or colectomy.
Interpretation bands for the Travis Criteria. Apply clinical judgement and local guidance.
References
- Travis SP et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38(6):905–910.
Related
Curated clinical cross-links plus same-class fallbacks.
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) · Inflammatory Bowel Disease
- Simplified Endoscopic Score for Crohn's Disease (SES-CD) · Inflammatory Bowel Disease
- Dimethyl Fumarate · Disease-Modifying Therapy — Relapsing-Remitting Multiple Sclerosis
- Natalizumab · Disease-Modifying Therapy — MS (Anti-VLA-4 Monoclonal Antibody)
- Interferon Beta-1a · Disease-Modifying Therapy — MS (Interferon)
- Apomorphine · Dopamine Agonist — Parkinson's Disease Rescue / Continuous Infusion
- Ocrelizumab · Multiple Sclerosis — Disease-Modifying Therapy
- Fingolimod · Multiple Sclerosis — Disease-Modifying Therapy
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.